evalu
children
fever
challeng
particularli
low
middl
incom
countri
lmic
febril
child
subsaharan
africa
may
mild
selfresolv
viral
infect
may
suffer
bacteri
sepsi
caus
disabl
death
histor
febril
ill
much
africa
treat
empir
malaria
due
limit
avail
diagnost
risk
untreat
malaria
progress
lifethreaten
ill
strategi
chang
follow
revis
guidelin
world
health
organ
recommend
limit
malaria
therapi
confirm
diagnosi
howev
standard
recommend
manag
febril
children
malaria
lack
increas
knowledg
preval
nonmalari
pathogen
associ
fever
need
inform
manag
strategi
febril
children
especi
low
resourc
set
advanc
genom
sequenc
hold
promis
address
global
infecti
diseas
challeng
enabl
unbias
detect
microbi
pathogen
use
design
direct
diagnost
improv
surveil
lmic
unbias
approach
detect
sequencebas
diagnost
led
success
detect
pathogen
rare
complex
case
tradit
method
fail
sequencebas
diagnost
complementari
serolog
assay
may
contribut
better
understand
pathogen
landscap
lmic
toward
aim
conduct
exploratori
retrospect
mng
analysi
sampl
avail
cohort
children
hospit
rural
uganda
febril
ill
character
potenti
pathogen
associ
fever
result
includ
detect
novel
viral
speci
suggest
mng
like
valuabl
tool
arsen
assay
understand
microbi
landscap
human
infect
octob
decemb
children
admit
tororo
district
hospit
enrol
tabl
mean
age
iqr
month
femal
chief
symptom
report
addit
fever
cough
vomit
diarrhea
convuls
top
admit
diagnos
respiratori
tract
infect
gastroenteritisdiarrhea
septicemia
tabl
data
blood
sampl
collect
thick
blood
smear
identifi
p
falciparum
sampl
underw
mng
analysi
tabl
b
data
mng
perform
rna
extract
serum
np
swab
stool
sampl
follow
librari
prepar
mean
million
iqr
million
pairedend
read
obtain
per
sampl
sequenc
statist
data
one
batch
serum
sampl
singl
read
rather
pairedend
read
produc
bioinformat
analysi
carri
use
idseq
pipelin
cloudbas
opensourc
platform
design
detect
microb
metagenom
data
http
githubcomchanzuckerbergidseqdag
incorpor
sever
featur
previous
develop
pathogen
detect
pipelin
section
discuss
mng
result
identifi
given
sampl
type
detail
find
microb
identifi
everi
patient
along
total
read
per
million
rpm
report
tabl
b
tabl
c
data
respect
least
one
microbi
speci
detect
serum
sampl
one
microb
detect
sampl
fig
microbi
speci
identifi
serum
individu
commonli
identifi
microb
plasmodium
falciparum
parvoviru
p
falciparum
detect
sampl
patient
report
smearposit
mng
detect
plasmodium
spp
addit
sampl
smear
neg
p
falciparum
p
malaria
virus
detect
serum
includ
human
immunodefici
viru
hepat
viru
rotaviru
human
herpesviru
hhv
type
hhv
type
hhv
type
human
rhinoviru
hrv
c
hrva
enterovirus
enteroviru
coxsackieviru
echoviru
human
parechoviru
hepat
b
viru
novel
orthobunyaviru
describ
greater
detail
human
cardioviru
saffold
viru
mamastroviru
norwalk
viru
fig
multipl
virus
detect
serum
patient
plasmodium
infect
sampl
tabl
three
four
identifi
parvoviru
case
associ
p
falciparum
addit
gb
viru
c
torqu
teno
viru
ttv
unknown
clinic
signific
identifi
serum
children
respect
report
associ
immunosuppress
ttv
abund
interestingli
prior
studi
report
higher
abund
ttv
children
fever
np
swab
collect
process
patient
admiss
diagnos
pneumonia
respiratori
tract
infect
bronchiol
tabl
chest
imag
avail
assess
diagnos
np
sampl
contain
least
viral
speci
fig
microb
meet
requir
cutoff
sampl
hrva
hrvc
preval
follow
respiratori
syncyti
viru
rsv
cytomegaloviru
influenza
b
coronaviru
respiratori
virus
identifi
includ
influenza
hrvb
human
mastadenoviru
b
type
three
human
parainfluenza
viru
type
type
metapneumoviru
coronaviru
avian
coronaviru
coxsackieviru
coxsackieviru
polyomavirus
ki
virus
identifi
typic
consid
respiratori
pathogen
includ
hepat
viru
hepat
b
viru
parvoviru
mamastroviru
bwamba
orthobunyaviru
betapapillomaviru
rotaviru
addit
ttv
found
np
swab
sampl
includ
one
sampl
gemykrogviru
ttv
patient
mng
identifi
respiratori
viral
coinfect
commonli
hrvc
n
hrva
n
tabl
microbi
speci
identifi
np
swab
serum
sampl
six
patient
independ
sequenc
run
one
hrva
hrvc
hepat
viru
hepat
b
viru
rotaviru
parvoviru
bacteria
identifi
np
sampl
includ
four
domin
genera
togeth
compris
microbi
haemophilu
streptococcu
corynebacterium
given
divers
loss
microbi
flora
lower
respiratori
tract
sampl
correl
pneumonia
compar
simpson
divers
index
sdi
patient
without
clinic
diagnos
respiratori
tract
infect
found
signific
differ
sdi
upper
airway
sampl
patient
mean
sdi
iqr
without
mean
sdi
iqr
p
diagnos
respiratori
infect
fig
among
stool
sampl
collect
sequenc
potenti
nonbacteri
pathogen
detect
sampl
three
common
microb
identifi
rotaviru
cryptosporidium
human
parechoviru
sequenc
provid
enough
inform
type
identifi
human
parechoviru
seven
children
addit
microb
identifi
two
rotaviru
human
parechoviru
one
rotaviru
cryptosporidium
rotaviru
enteroviru
cryptosporidium
human
parechoviru
cryptosporidium
norwalk
viru
giardia
human
parechoviru
five
sampl
also
blastocysti
homini
protozoan
uncertain
pathogen
repres
genom
virus
identifi
studi
assembl
deposit
genbank
access
number
section
describ
detail
novel
orthobunyaviru
identifi
serum
one
individu
two
novel
hrvc
speci
identifi
two
individu
divers
influenza
b
virus
assembl
nasopharynx
five
individu
studi
genom
divers
influenza
b
detail
given
potenti
implic
inform
vaccin
design
includ
influenza
analysi
abl
assembl
complet
genom
sequenc
one
individu
serum
one
patient
admit
clinic
diagnosi
malaria
pneumonia
contain
novel
orthobunyaviru
addit
p
falciparum
assembl
nearcomplet
genom
comparison
exist
orthobunyaviru
genom
indic
sequenc
includ
l
code
region
respect
fig
averag
read
coverag
across
segment
phylogenet
comparison
show
novel
viru
significantli
diverg
known
orthobunyavirus
share
amino
acid
ident
closest
known
rel
calchaqui
viru
kaeng
khoi
viru
anophel
viru
fig
viru
isol
patient
nyangol
villag
tororo
propos
name
nyangol
viru
consist
nomenclatur
guidelin
famili
bunyavirida
addit
second
orthobunyaviru
bwamba
viru
identifi
np
swab
sampl
patient
admit
rash
sepsi
diarrhea
insuffici
sampl
sequenc
read
preclud
genom
assembl
viru
within
speci
rhinoviru
assembl
de
novo
total
hrvc
mean
coverag
hrva
mean
coverag
genom
bp
hrva
nine
hrvc
genom
complet
coverag
region
use
defin
enteroviru
type
uniqu
hrv
type
defin
similar
gene
found
three
hrva
eight
hrvc
type
cohort
one
individu
harbor
two
distinct
hrva
type
genom
pairwis
ident
pairwis
ident
addit
assembl
two
novel
hrvc
speci
two
patient
admit
gastroenter
patient
id
pneumonia
malaria
diarrhea
patient
id
share
nucleotid
sequenc
ident
compar
closest
known
hrvc
access
respect
fig
picornaviru
work
group
establish
novel
hrvc
exhibit
least
nucleotid
sequenc
diverg
gene
qualifi
two
novel
assembl
influenza
b
genom
segment
meancoverag
six
seven
sampl
contain
influenza
b
viru
one
sampl
insuffici
sequenc
read
virus
assembl
similar
ident
viru
includ
vaccin
recommend
northern
hemispher
southern
hemispher
influenza
season
access
number
ugandan
virus
three
four
major
epitop
loop
loop
helix
surround
region
ident
ser
thr
substitut
observ
amino
acid
loop
compar
viru
better
understand
microbi
agent
caus
fever
african
children
need
inform
develop
better
diagnost
algorithm
therapeut
guidelin
public
health
strategi
perform
exploratori
retrospect
studi
unbias
mng
variou
tissu
type
determin
whether
technolog
potenti
contribut
understand
etiolog
fever
african
children
limit
sampl
set
mng
identifi
wide
rang
potenti
pathogen
includ
three
novel
viral
speci
studi
evalu
caus
febril
ill
african
children
focus
limit
number
pathogen
studi
febril
children
tanzania
util
serolog
cultur
molecular
assay
virus
account
lower
respiratori
infect
system
infect
upper
respiratori
infect
addit
studi
children
malaria
bacteremia
febril
children
kenya
report
pathogen
spot
fever
group
rickettsia
influenza
adenoviru
parainfluenza
viru
q
fever
rsv
malaria
scrub
typhu
human
metapneumoviru
group
streptococcu
typhu
group
rickettsia
anoth
studi
report
bacteremia
children
admit
referr
hospit
uganda
addit
patient
across
age
group
sever
febril
ill
bacteremia
detect
north
africa
east
africa
west
africa
small
studi
plasmodium
falciparum
identifi
serum
children
human
rhinovirus
c
domin
nasopharyng
swab
children
rotaviru
identifi
stool
sampl
children
studi
np
swab
serum
sampl
microbi
speci
met
threshold
detect
proport
consist
previou
report
unbias
sequenc
approach
design
identifi
potenti
pathogen
also
limit
high
cost
infrastructur
need
given
exploratori
natur
mng
studi
ascertain
popul
level
incid
preval
particular
infect
expect
serum
sampl
p
falciparum
commonli
identifi
discrep
seen
compar
blood
smear
read
fals
posit
smear
probabl
due
error
slide
read
common
problem
resourc
clinic
fals
neg
smear
due
expect
greater
sensit
mng
identif
p
falciparum
children
submicroscop
parasitemia
uncertain
whether
fever
ascrib
malaria
fact
mani
children
p
falciparum
addit
microb
identifi
interestingli
three
four
case
parvoviru
found
associ
p
falciparum
coinfect
associ
sever
anemia
lifethreaten
consequ
np
stool
sampl
given
nasopharynx
intestin
normal
colon
commens
bacteria
lack
sampl
healthi
ugandan
control
focus
nonbacteri
speci
hrv
commonli
identifi
viru
np
swab
sampl
consist
find
previous
report
subsaharan
africa
develop
countri
hrvc
frequent
encount
follow
hrva
hrvb
similar
distribut
hrv
previous
report
kenya
identifi
two
novel
hrvc
speci
approxim
ident
close
relat
previous
describ
hrvc
speci
overal
detect
least
three
hrva
eight
hrvc
type
cocircul
tororo
district
note
collect
period
lethal
hrvc
outbreak
report
chimpanze
kibal
nation
park
western
uganda
hrvc
modestli
relat
isol
observ
studi
nucleotid
ident
amino
acid
ident
fig
result
confirm
wide
spectrum
hrv
infect
ugandan
children
addit
hrv
detect
number
known
respiratori
virus
includ
rsv
human
parainfluenza
virus
human
coronavirus
adenoviru
diarrheal
diseas
one
lead
caus
death
children
africa
approxim
febril
children
studi
present
diarrhea
due
logist
constraint
stool
specimen
avail
case
rotaviru
lead
caus
pediatr
diarrhea
worldwid
commonli
identifi
microb
cohort
rotaviru
vaccin
known
highli
effect
yet
implement
uganda
need
clear
addit
rotaviru
detect
cryptosporidium
noroviru
giardia
b
homini
sever
enterovirus
stool
specimen
enterovirus
hrvc
mamastroviru
also
identifi
serum
three
children
clinic
diagnos
gastroenter
diarrhea
unbias
inspect
microbi
sequenc
sera
reveal
novel
member
orthobunyaviru
genu
tent
name
nyangol
viru
identifi
along
p
falciparum
child
clinic
diagnos
malaria
pneumonia
viru
surprisingli
diverg
known
virus
averag
amino
acid
similar
nearest
known
rel
includ
calchaqui
anophel
kaeng
khoi
virus
mosquito
propos
vector
calchaqui
anophel
virus
kaeng
khoi
viru
isol
bedbug
antibodi
virus
detect
human
sera
role
human
pathogen
uncertain
howev
orthobunyavirus
respons
sever
human
ill
eg
oropouch
bunyamwera
viru
california
enceph
viru
la
cross
viru
jamestown
canyon
viru
cach
valley
viru
coverag
depth
assembl
nyangol
viru
genom
patient
suggest
signific
viremia
unknown
whether
identifi
viru
respons
patient
febril
ill
np
swab
analysi
identifi
anoth
orthobunyaviru
bwamba
viru
child
admit
rash
sepsi
diarrhea
viru
previous
describ
caus
fever
uganda
identif
two
orthobunyavirus
includ
one
novel
viru
small
sampl
febril
ugandan
children
suggest
landscap
previous
unidentifi
virus
potenti
infect
african
children
potenti
caus
febril
ill
significantli
explor
addit
pathogen
identif
capac
mng
provid
viral
strain
resolut
suggest
util
monitor
vaccin
efficaci
assess
preval
vaccinetarget
versu
nontarget
strain
case
influenza
b
viru
recommend
vaccin
highli
conserv
viru
present
uganda
season
exploratori
pilot
studi
import
limit
first
sampl
collect
randomli
rather
retrospect
conveni
sampl
due
logist
constraint
result
necessarili
repres
pathogen
infect
ugandan
children
particular
lack
identif
bacteremia
studi
subject
may
due
rel
pauciti
sever
ill
compar
studi
second
sampl
collect
period
three
month
henc
unabl
comment
season
trend
identifi
pathogen
third
clinic
evalu
children
follow
standard
rural
african
hospit
diagnost
evalu
limit
physic
examin
malaria
blood
smear
studi
design
compar
mng
clinic
laboratori
assay
clear
learn
link
rigor
clinic
evalu
mng
result
therebi
comprehens
assess
associ
clinic
syndrom
specif
pathogen
fourth
healthi
control
popul
recruit
studi
henc
unabl
includ
background
model
filter
commens
microbi
speci
specif
ugandan
microbiom
fifth
unabl
use
orthogon
techniqu
pcr
confirm
microbi
speci
identifi
mng
due
lack
sampl
avail
given
limit
hesit
integr
clinic
specimen
per
sampl
basi
rather
present
portrait
microb
identifi
febril
children
reader
interest
breakdown
microbi
speci
sampl
collect
per
child
tabl
b
data
contain
inform
futur
metagenom
studi
includ
rigor
clinic
microbiolog
phenotyp
along
sampl
collect
healthi
individu
would
facilit
design
appropri
background
model
identifi
potenti
pathogen
confirm
use
orthogon
techniqu
despit
limit
studi
provid
import
snapshot
caus
fever
african
children
could
identifi
avail
diagnost
suggest
mng
import
tool
futur
investig
given
yield
novel
speci
small
studi
alon
like
expand
use
approach
continu
yield
increasingli
rich
portrait
microbi
divers
associ
diseas
region
studi
children
admit
tororo
district
hospit
tororo
uganda
febril
ill
potenti
subject
identifi
clinic
staff
notifi
studi
personnel
subsequ
evalu
children
studi
elig
inclus
criteria
age
month
admiss
tororo
district
hospit
acut
ill
document
axillari
temperatur
admiss
within
hour
admiss
provis
inform
consent
parent
guardian
studi
procedur
exclus
criterion
unwilling
inabl
parentsguardian
provid
consent
serum
nasopharyng
np
swab
sampl
collect
children
four
children
one
two
sampl
type
success
collect
although
children
present
symptom
diarrhea
stool
sampl
avail
due
logist
constraint
sampl
collect
process
includ
analysi
np
swab
serum
collect
enrol
subject
within
hour
hospit
admiss
approxim
ml
serum
collect
phlebotomi
sampl
centrifug
room
temperatur
serum
store
np
swab
sampl
collect
floqswab
swab
copan
place
cryovial
trizol
invitrogen
store
within
min
collect
subject
acut
diarrhea
three
loos
wateri
stool
hour
stool
collect
clean
plastic
contain
store
within
min
collect
sampl
store
shipment
dri
ice
ucsf
sequenc
clinic
inform
obtain
interview
parent
guardian
specif
data
enter
onto
standard
case
record
form
includ
admiss
diagnosi
physic
examin
well
malaria
blood
smear
result
malaria
diagnosi
thick
blood
smear
giemsa
stain
evalu
tororo
district
hospit
laboratori
personnel
follow
routin
standardofcar
practic
effort
made
improv
routin
practic
malaria
smear
read
repres
routin
standardofcar
rather
optim
qualiti
control
read
shipment
univers
california
san
francisco
rna
extract
clinic
sampl
well
posit
hela
cell
neg
water
control
unbias
cdna
librari
gener
use
previous
describ
method
see
section
sequenc
librari
prepar
metagenom
librari
prepar
respect
barcod
sampl
pool
size
select
blue
pippin
run
illumina
obtain
base
pair
bp
pairedend
read
microbi
pathogen
identifi
raw
sequenc
read
use
idseq
portal
http
idseqnet
cloudbas
opensourc
bioinformat
platform
design
detect
microb
metagenom
data
idseq
scalabl
cloud
base
implement
previous
publish
pipelin
see
fig
brief
initi
host
read
filter
perform
use
splice
transcript
align
refer
star
algorithm
follow
remov
duplicatelow
qualiti
low
complex
sequenc
next
read
align
host
genom
interest
use
remov
remain
host
read
nonhuman
read
align
ncbi
nucleotid
protein
databas
use
gsnapl
rapsearch
respect
addit
read
identifi
assess
individu
use
blast
verifi
specif
viru
idseq
script
user
instruct
avail
http
githubcomchanzuckerbergidseqdag
graphic
user
interfac
web
applic
sampl
upload
avail
http
githubcomchanzuckerbergidseqweb
distinguish
potenti
pathogen
ubiquit
environment
agent
includ
laboratori
reagent
contamin
skin
commens
flora
zscore
calcul
nucleic
acid
protein
align
genu
rel
background
nontempl
water
control
addit
previous
publish
set
uninfect
clinic
mng
sampl
csf
sampl
acquir
lumbar
punctur
uninfect
control
includ
background
model
extens
represent
skin
microbiom
given
need
punctur
skin
human
papillomaviru
identifi
posit
hela
cell
control
studi
report
speci
greater
read
per
million
rpm
zscore
nucleic
acid
protein
align
detect
serum
stool
np
sampl
chose
report
speci
satisfi
criteria
rather
restrict
particular
speci
offer
unbias
represent
microb
present
sampl
idseq
use
cdhitdup
tool
compress
duplic
read
henc
final
assign
rpm
given
sampl
repres
coverag
across
genom
rather
singl
portion
consist
previou
studi
low
level
index
bleed
barcod
hop
assign
sequenc
read
wrong
barcodeindex
observ
within
nontempl
water
control
sampl
account
barcod
misassign
microb
found
one
sampl
report
present
level
least
four
time
level
misassign
read
observ
control
sampl
given
extrem
high
level
rotaviru
found
stool
sampl
sampl
run
duplic
microb
identifi
replic
present
level
least
four
time
number
read
misassign
control
sampl
report
read
identifi
given
microb
speciesspecif
report
correspond
genu
np
stool
sampl
nasopharynx
intestin
normal
colon
commens
bacteria
lack
healthi
ugandan
np
stool
sampl
serv
control
nonbacteri
speci
report
though
analyz
np
microbiom
divers
see
comprehens
character
genom
identifi
microb
pairedread
iter
contig
extens
price
assembl
st
petersburg
genom
assembl
spade
use
de
novo
assembl
short
read
sequenc
larger
contigu
sequenc
contig
assembl
contig
queri
nation
center
biotechnolog
inform
ncbi
nucleotid
nt
databas
use
basic
local
align
search
tool
blast
identifi
closest
relat
microb
genbank
annot
file
genom
sequenc
record
correspond
highest
score
align
use
identifi
potenti
featur
within
de
novo
assembl
genom
geneiou
use
annot
newli
assembl
genom
refer
genom
multipl
sequenc
align
phylogenet
analys
download
ncbi
multipl
sequenc
nucleotid
align
gener
use
default
set
use
identifi
bestfit
evolutionari
model
use
bestfit
model
evolut
reconstruct
maximumlikelihood
phylogeni
use
raxmlng
use
default
set
annot
protein
domain
novel
orthobunyaviru
perform
use
interpro
webserv
well
direct
align
previous
known
orthobunyavirus
topcon
webserv
use
identif
transmembran
region
signal
peptid
netnglyc
server
http
wwwcbsdtudkservicesnetnglyc
identif
glycosyl
site
appli
sdi
evalu
alpha
divers
microb
identifi
np
sampl
analysi
patient
stratifi
two
categori
base
clinic
assign
respiratori
infect
admit
diagnosi
pneumonia
respiratori
tract
infect
bronchiol
n
syndrom
n
case
unknown
admit
diagnosi
exclud
sdi
calcul
r
use
packag
genuslevel
read
per
million
valu
microb
includ
bacteria
wilcox
rank
sum
test
use
evalu
differ
sdi
patient
two
categori
